Format

Send to

Choose Destination
Lancet Infect Dis. 2005 Jun;5(6):341-8.

Problem pathogens: extra-intestinal complications of Salmonella enterica serotype Typhi infection.

Author information

1
Center for Infectious Diseases, Baylor College of Medicine, Houston, Texas 77030, USA. dhuang1@bcm.tmc.edu

Abstract

Typhoid fever, caused by Salmonella enterica seroptype Typhi (S typhi), has an estimated worldwide prevalence of 12-33 million cases. The pathogenesis of this disease depends on the ingested inoculum size of S typhi, the virulence of the strain, the host's immune response and previous exposure, and local protective factors. Numerous extra-intestinal complications can occur with S typhi infection, including the involvement of the central nervous system (3-35%), cardiovascular system (1-5%), pulmonary system (1-86%), bone and joints (< or =1%), hepatobiliary system (1-26%), genitourinary system (<1%), and others. Due to an increase in multidrug-resistant S typhi, fluoroquinolones and third-generation cephalosporins have been increasingly used for typhoid fever and its complications. We describe the epidemiology, clinical manifestations, pathogenesis, and treatment of extra-intestinal S typhi infections.

Comment in

PMID:
15919620
DOI:
10.1016/S1473-3099(05)70138-9
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center